Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity

Choi, 2000, Loss of heterozygosity at chromosome segments 8p22 and 8p11.2-21.1 in transitional-cell carcinoma of the urinary bladder, Int. J. Cancer, 86, 501, 10.1002/(SICI)1097-0215(20000515)86:4<501::AID-IJC9>3.0.CO;2-# Ohgaki, 1999, Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22, Genes Chromosomes Cancer, 25, 1, 10.1002/(SICI)1098-2264(199905)25:1<1::AID-GCC1>3.0.CO;2-3 Takle, 1996, Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer, Oncogene, 12, 1083 Bova, 1996, Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer, Genomics, 35, 46, 10.1006/geno.1996.0321 Jenkins, 1998, Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer, Genes Chromosomes Cancer, 21, 131, 10.1002/(SICI)1098-2264(199802)21:2<131::AID-GCC9>3.0.CO;2-1 Kagan, 1995, Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes, Oncogene, 11, 2121 Macoska, 1995, Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer, Cancer Res., 55, 5390 Matsuyama, 1994, Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization, Oncogene, 9, 3071 Prasad, 1998, Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site, Genes Chromosomes Cancer, 23, 255, 10.1002/(SICI)1098-2264(199811)23:3<255::AID-GCC8>3.0.CO;2-0 Suzuki, 1995, Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2Mb region of 8p22-p21.3, Genes Chromosomes Cancer, 13, 168, 10.1002/gcc.2870130306 El-Naggar, 1998, Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma, Oncogene, 16, 2983, 10.1038/sj.onc.1201808 Ishwad, 1999, Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer, Int. J. Cancer, 80, 25, 10.1002/(SICI)1097-0215(19990105)80:1<25::AID-IJC6>3.0.CO;2-G Sunwoo, 1996, Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer, Genes Chromosomes Cancer, 16, 164, 10.1002/(SICI)1098-2264(199607)16:3<164::AID-GCC2>3.0.CO;2-X Wu, 1997, Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas, Genes Chromosomes Cancer, 20, 347, 10.1002/(SICI)1098-2264(199712)20:4<347::AID-GCC5>3.0.CO;2-1 Emi, 1992, Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer, Cancer Res., 52, 5368 Fujiwara, 1994, A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer, Genes Chromosomes Cancer, 10, 7, 10.1002/gcc.2870100103 Pineau, 1999, Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma, Oncogene, 18, 3127, 10.1038/sj.onc.1202648 Chuaqui, 1995, Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas, Cancer Res., 55, 4995 Yaremko, 1995, Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers, Genes Chromosomes Cancer, 13, 186, 10.1002/gcc.2870130308 Yokota, 1999, Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1, Cancer, 85, 447, 10.1002/(SICI)1097-0142(19990115)85:2<447::AID-CNCR24>3.0.CO;2-Y Baffa, 2000, Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer, Clin. Cancer Res., 6, 1372 Lassus, 2001, Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4, Lab. Invest., 81, 517, 10.1038/labinvest.3780260 Wright, 1998, Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas, Oncogene, 17, 1185, 10.1038/sj.onc.1202028 Bruch, 1998, Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q, Genes Chromosomes Cancer, 23, 167, 10.1002/(SICI)1098-2264(199810)23:2<167::AID-GCC10>3.0.CO;2-L Hovey, 1998, Genetic alterations in primary bladder cancers and their metastases, Cancer Res., 58, 3555 Kallioniemi, 1995, Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridisation, Genes Chromosomes Cancer, 12, 213, 10.1002/gcc.2870120309 Richter, 1999, Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer, Cancer Res., 59, 5687 Wagner, 1997, Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer, Am. J. Pathol., 151, 753 Utada, 2000, Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas, Cancer, 88, 1410, 10.1002/(SICI)1097-0142(20000315)88:6<1410::AID-CNCR19>3.0.CO;2-X Yaremko, 1996, Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer, Genes Chromosomes Cancer, 16, 189, 10.1002/(SICI)1098-2264(199607)16:3<189::AID-GCC6>3.0.CO;2-V Crundwell, 1996, Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer, Int. J. Cancer, 69, 295, 10.1002/(SICI)1097-0215(19960822)69:4<295::AID-IJC10>3.0.CO;2-5 Haggman, 1997, Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma, Urology, 50, 643, 10.1016/S0090-4295(97)00304-X Emmert-Buck, 1995, Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia, Cancer Res., 55, 2959 Qin, 1999, The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma, Cancer Res., 59, 5662 Halling, 1999, Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers, J. Natl Cancer Inst., 91, 1295, 10.1093/jnci/91.15.1295 Hirano, 2001, Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer, Clin. Cancer Res., 7, 876 Scholnick, 1996, Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx, J. Natl Cancer Inst., 88, 1676, 10.1093/jnci/88.22.1676 Martinez-Climent, 2001, Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma, Blood, 98, 3479, 10.1182/blood.V98.12.3479 Kelemen, 1994, Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma, Genes Chromosomes Cancer, 11, 195, 10.1002/gcc.2870110308 Thompson, 1995, Apoptosis in the pathogenesis and treatment of disease, Science, 267, 1456, 10.1126/science.7878464 Arai, 1998, Genomic organization and mutation analyses of the DR5/TRAIL receptor 2 gene in colorectal carcinomas, Cancer Lett., 133, 197, 10.1016/S0304-3835(98)00230-4 Golstein, 1997, Cell death: TRAIL and its receptors, Curr. Biol., 7, R750, 10.1016/S0960-9822(06)90000-1 Ashkenazi, 1998, Death receptors: signaling and modulation, Science, 281, 1305, 10.1126/science.281.5381.1305 Ichikawa, 2001, Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity, Nat. Med., 7, 954, 10.1038/91000 Lee, 1999, Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers, Cancer Res., 59, 5683 Pai, 1998, Rare loss-of-function mutation of a death receptor gene in head and neck cancer, Cancer Res., 58, 3513 Shin, 2001, Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers, Cancer Res., 61, 4942 Lee, 2001, Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma, Oncogene, 20, 399, 10.1038/sj.onc.1204103 Park, 2001, Inactivating mutations of KILLER/DR5 gene in gastric cancers, Gastroenterology, 121, 1219, 10.1053/gast.2001.28663 Wu, 1997, KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene, Nat. Genet., 17, 141, 10.1038/ng1097-141 Wu, 2000, TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer, Anticancer Res., 20, 4525 Monni, 1996, DNA copy number changes in diffuse large B-cell lymphoma-comparative genomic hybridization study, Blood, 87, 5269, 10.1182/blood.V87.12.5269.bloodjournal87125269 Ohata, 1993, Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma, Genes Chromosomes Cancer, 7, 85, 10.1002/gcc.2870070204 van der Bosch, 1992, Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines, Genes Chromosomes Cancer, 5, 91, 10.1002/gcc.2870050114 Grossman, 1986, Improved growth of human urothelial carcinoma cell cultures, J. Urol., 136, 953, 10.1016/S0022-5347(17)45139-1 Rigby, 1970, A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure, Br. J. Cancer, 24, 746, 10.1038/bjc.1970.89 Kyriazis, 1984, Morphologiccal, biological and biochemical characteristics of human bladder transitional cel carcinomas grown in tissue culture, Cancer Res., 44, 3997 Paulie, 1983, Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines, Int. J. Cancer, 31, 297, 10.1002/ijc.2910310308 Williams, 1980, Human urologic cancer cell lines, Invest. Urol., 17, 359 Elliot, 1974, Characterization of a cell line from human transitional cell cancer of the urinary tract, J. Natl Cancer Inst., 53, 1341, 10.1093/jnci/53.5.1341 Bubenik, 1973, Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen, Int. J. Cancer, 11, 765, 10.1002/ijc.2910110327 Rasheed, 1977, Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses, J. Natl Cancer Inst., 58, 881, 10.1093/jnci/58.4.881 Williams, 2002, Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines, Genes Chromosomes Cancer, 34, 86, 10.1002/gcc.10050 O'Toole, 1978, Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma, Br. J. Cancer, 38, 64, 10.1038/bjc.1978.164 O'Toole, 1976, A cell line (SCaBER) derived from squamous cell carcinoma of the human urinary bladder, Int. J. Cancer, 17, 707, 10.1002/ijc.2910170604 Knowles, 1993, Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms, Oncogene, 8, 1357 Keen, 1994, Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder, Oncogene, 9, 2083 Screaton, 1997, TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL, Curr. Biol., 7, 693, 10.1016/S0960-9822(06)00297-1 Lee, 1999, Two novel genes in the center of the 11p15 imprinted domain escape genomic imprinting, Hum. Mol. Genet., 8, 683, 10.1093/hmg/8.4.683 Lee, 2001, Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma, Cancer Res., 61, 6688